Stoke Therapeutics, Inc.

STOK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$127,983$191,442$113,556$144,895
Short-Term Investments$88,916$9,952$116,039$74,915
Receivables$700$64$588$132
Inventory$0$0$0$0
Other Curr. Assets$15,157$13,881$13,887$9,276
Total Curr. Assets$232,756$215,339$244,070$229,218
Property Plant & Equip (Net)$8,254$12,434$11,428$9,078
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$29,824$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$721$569$569$569
Total NC Assets$38,799$13,003$11,997$9,647
Other Assets$0$0$0$0
Total Assets$271,555$228,342$256,067$238,865
Liabilities
Payables$2,498$1,695$766$2,385
Short-Term Debt$2,322$2,062$2,359$1,507
Tax Payable$0$0$0$0
Deferred Revenue$18,991$15,309$14,880$0
Other Curr. Liab.$16,245$11,753$13,389$13,247
Total Curr. Liab.$40,056$30,819$31,394$17,139
LT Debt$0$0$0$0
Deferred Rev, NC$0$33,074$36,856$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,478$4,884$2,968$3,949
Total NC Liab.$2,478$37,958$39,824$3,949
Other Liabilities$0$0$0$0
Cap. Leases$2,322$2,062$2,359$1,507
Total Liabilities$42,534$68,777$71,218$21,088
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$4$4
Retained Earnings-$490,830-$401,849-$297,150-$196,083
AOCI-$151-$24-$1,175-$168
Other Equity$719,997$561,433$483,170$414,024
Total Equity$229,021$159,565$184,849$217,777
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$271,555$228,342$256,067$238,865
Net Debt-$125,661-$189,380-$111,197-$143,388
Stoke Therapeutics, Inc. (STOK) Financial Statements & Key Stats | AlphaPilot